LMTC - Leuven Medical Technology Centre
From 01-01-2008 to 31-12-2011
Website: http://www.kuleuven.be/lmtc/
Description
Encouraged by a strong technological progress, medicine has evolved substantially during the last century. It is impossible to imagine hospitals, rehabilitation centers and practices of doctors and paramedics today without computers and other technological equipment. Ageing and the wish for an improved medical care and quality of life – also at an advanced age – increase the need for biomedical technology, which is an evolution that also offers new economic opportunities.For a considerable time research groups within the University Hospitals and the Katholieke Universiteit Leuven are involved in research and development in biomedical technology. Bundling these activities under an umbrella organization offers advantages at different levels:
The Leuven Medical Technology Centre facilitates interdisciplinary collaboration within the University Hospitals and the Katholieke Universiteit Leuven, bringing together a unique combination of competence and know-how.
The centre strengthens the exploitation potential of the medical technology portfolio, by facilitating the contacts with financing instances, industry, and governmental bodies.
Leuven-MTC offers the opportunity to embed education at the Katholieke Universiteit Leuven - more specifically the Master in Biomedical Engineering and the Master in Biomedical Sciences - in a strong research environment.
Bringing together a large critical mass in medical technology research and development, Leuven-MTC makes its high quality research visible.
The Leuven Medical Technology Centre supports the development of medical technology throughout the Association K.U.Leuven.
Team
Financing
Funding: -
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.